Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 2/20 | 0.33 |
| ▸ | RARB | P10826 | 1/20 | 0.31 |
| ▸ | RARG | P13631 | 1/20 | 0.31 |
| ▸ | RXRB | P28702 | 1/20 | 0.31 |
| ▸ | RXRG | P48443 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38658204 | 0.88 | — | — | |
| SCHEMBL1618923 | 0.70 | CA1 (0.30) | — | |
| SCHEMBL11599145 | 0.69 | RXRA (0.42) | RXRARARBRARGRXRBRXRG | |
| SCHEMBL22982079 | 0.69 | — | — | |
| SCHEMBL6939291 | 0.67 | RXRA (0.36) | RXRARARBRARGRXRBRXRG | |
| SCHEMBL3195465 | 0.67 | NPC1 (0.30) | — | |
| SCHEMBL8308767 | 0.67 | RXRA (0.36) | RXRARARBRARGRXRBRXRG | |
| SCHEMBL5009416 | 0.67 | RXRA (0.41) | RXRARARBRARGRXRBRXRG | |
| SCHEMBL29401105 | 0.67 | RXRA (0.41) | RXRARARBRARGRXRBRXRG | |
| SCHEMBL9986176 | 0.67 | RXRA (0.33) | RXRARARBRARGRXRBRXRG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026101707-A1 | JULOLIDINE SUBSTITUTED METALLOCENE CATALYSTS | ExxonMobil Technology and Engineering Company (US) | 2026-05-15 | — | — | WO | claimed |
| WO-2026101707-A1 | JULOLIDINE SUBSTITUTED METALLOCENE CATALYSTS | ExxonMobil Technology and Engineering Company (US) | 2026-05-15 | — | — | WO | disclosed |
| US-12617880-B2 | Compounds for use in catalyst compositions for the production of polyolefins | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2026-05-05 | — | — | US | disclosed |
| EP-4716709-A1 | POLETHYLENES, CATALYSTS FOR THEIR POLYMERIZATION, AND FILMS THEREOF | ExxonMobil Technology and Engineering Company (US) | 2026-04-01 | — | — | EP | disclosed |
| EP-4716706-A1 | CATALYSTS, POLYETHYLENES, POLYMERIZATIONS THEREOF, AND FILMS THEREOF | ExxonMobil Technology and Engineering Company (US) | 2026-04-01 | — | — | EP | disclosed |
| WO-2024242931-A1 | CATALYSTS, POLYETHYLENES, POLYMERIZATIONS THEREOF, AND FILMS THEREOF | ExxonMobil Technology and Engineering Company (US) | 2024-11-28 | — | — | WO | disclosed |
| WO-2024242932-A1 | POLETHYLENES, CATALYSTS FOR THEIR POLYMERIZATION, AND FILMS THEREOF | ExxonMobil Technology and Engineering Company (US) | 2024-11-28 | — | — | WO | disclosed |
| EP-3844196-B1 | SUBSTITUTED BIS-2-INDENYL METALLOCENE COMPOUNDS | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2023-03-08 | — | — | EP | disclosed |
| US-20220332861-A1 | COMPOUNDS FOR USE IN CATALYST COMPOSITIONS FOR THE PRODUCTION OF POLYOLEFINS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2022-10-20 | — | — | US | disclosed |
| US-11472895-B2 | Substituted bis-2-indenyl metallocene compounds | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2022-10-18 | — | — | US | disclosed |
| US-20110319578-A1 | TRANSITION METAL COMPOUND AND CATALYST FOR OLEFIN POLYMERIZATION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-29 | — | — | US | disclosed |
| US-7601666-B2 | Provide polymers having high molecular weight as well as good crystallinity preferably prepared at higher temperatures and productivities than otherwise possible | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2009-10-13 | — | — | US | disclosed |
| EP-1765841-B1 | OLEFIN POLYMERIZATION CATALYST SYSTEM AND PROCESS FOR USE THEREOF | EXXONMOBIL CHEM PATENTS INC (US) | 2008-10-08 | — | — | EP | disclosed |
| EP-1765841-A2 | OLEFIN POLYMERIZATION CATALYST SYSTEM AND PROCESS FOR USE THEREOF | Exxonmobil Chemical Patents Inc. (US) | 2007-03-28 | — | — | EP | disclosed |
| WO-2006010139-A2 | OLEFIN POLYMERIZATION CATALYST SYSTEM AND PROCESS FOR USE THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-01-26 | — | — | WO | disclosed |
| US-20060009595-A1 | Olefin polymerization catalyst system and process for use thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-01-12 | — | — | US | disclosed |
| EP-1157047-B1 | LIGANDS AND CATALYSTS FOR PRODUCING ELASTOMERIC PROPYLENE POLYMERS | BP CORP NORTH AMERICA INC (US) | 2003-04-23 | — | — | EP | disclosed |
| US-6479424-B1 | FOR PRODUCING OLEFIN POLYMERS AND ESPECIALLY ELASTOMERIC PROPYLENE POLYMERS | BP CORPORATION NORTH AMERICA INC. | 2002-11-12 | — | — | US | disclosed |
| EP-1157047-A1 | LIGANDS AND CATALYSTS FOR PRODUCING ELASTOMERIC PROPYLENE POLYMERS | BP Corporation North America Inc. (US) | 2001-11-28 | — | — | EP | disclosed |
| WO-2000035975-A1 | LIGANDS AND CATALYSTS FOR PRODUCING ELASTOMERIC PROPYLENE POLYMERS | BP CORPORATION NORTH AMERICA INC. (US) | 2000-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319578-A1 | TRANSITION METAL COMPOUND AND CATALYST FOR OLEFIN POLYMERIZATION | AP1M1, SOD1, YAP1 | RXRA 4489/4885RARB 4580/4885RARG 4722/4885 |
| US-12617880-B2 | Compounds for use in catalyst compositions for the production of polyolefins | PRMT5, CBR3, MET | RXRA 2035/4885RARB 2395/4885RARG 2475/4885 |
| US-20060009595-A1 | Olefin polymerization catalyst system and process for use thereof | OR10J3, CHRM2, CHRM1 | RXRA 1309/4885RARB 3171/4885RARG 2972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.